SCHEMBL6911527

SCHEMBL6911527

CC(Sc1cnc(NC(=O)C2CCCNC2)s1)c1ncc(C(C)(C)C)o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 20/20 0.68
CDK9 P50750 13/20 0.68
CCNE2 O96020 9/20 0.68
CCNE1 P24864 9/20 0.68
CDK7 P50613 3/20 0.54
CDK1 P06493 3/20 0.54
CCNB1 P14635 3/20 0.54
CCNT1 O60563 2/20 0.54
CCNH P51946 2/20 0.54
CCNB2 O95067 2/20 0.54
CDK4 P11802 2/20 0.54
CCND1 P24385 2/20 0.54
CCNB3 Q8WWL7 2/20 0.54
CIT O14578 1/20 0.54
CASK O14936 1/20 0.54
AURKA O14965 1/20 0.54
GAK O14976 1/20 0.54
DCLK1 O15075 1/20 0.54
MAP3K7 O43318 1/20 0.54
ULK1 O75385 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911670 0.83 CDK2 (0.56) CDK2CDK9CCNE2CCNE1CDK7
SCHEMBL4733685 0.81 CDK2 (1.00) CDK2CDK9CCNE2CCNE1CDK7
SCHEMBL4730239 0.81 CDK2 (1.00) CDK2CDK9CCNE2CCNE1CDK7
SCHEMBL4731289 0.81 CDK2 (1.00) CDK2CDK9CCNE2CCNE1CDK7
Hydrochloric Acid SCHEMBL6183918 0.80 CDK2 (0.98) CDK2CDK9CCNE2CCNE1CDK7
Hydrochloric Acid SCHEMBL6183632 0.80 CDK2 (0.98) CDK2CDK9CCNE2CCNE1CDK7
Hydrochloric Acid SCHEMBL6183623 0.80 CDK2 (0.98) CDK2CDK9CCNE2CCNE1CDK7
SCHEMBL6906735 0.80 CDK2 (0.70) CDK2CDK9CCNE2CCNE1CDK7
SCHEMBL6911788 0.79 CDK2 (0.83) CDK2CDK9CCNE2CCNE1CDK7
SCHEMBL6911525 0.79 CDK2 (0.83) CDK2CDK9CCNE2CCNE1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1429764-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Bristol-Myers Squibb Company (US) 2004-06-23 EP claimed
WO-2003020272-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2003-03-13 WO claimed